ArticleFrontiers in immunology2026
Multi-omics comparison of periodontitis and peri-implantitis identifies plasma cell enrichment as a shared feature and a periodontitis-associated endothelial-plasma cell APP-CD74 axis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To define the shared and divergent immune architecture of periodontitis (PD) and peri-implantitis (PI) and to identify intercellular communication programs linked to plasma cell accumulation. Methods: Differentially expressed genes (DEGs) in PD and PI versus healthy controls were identified from two bulk datasets (GSE223924, GSE106090); robust cross-dataset common DEGs underwent functional enrichment and protein-protein interaction analysis. A single-cell atlas (GSE171213) supported dual deconvolution (BisqueRNA, CIBERSORTx) and CellChat-based, plasma cell-centered communication inference. Key findings were independently validated in two additional periodontitis bulk cohorts (GSE10334, GSE16134) and an independent periodontitis single-cell dataset (GSE164241). Candidate ligand-receptor interactions were evaluated by spatial transcriptomics (GSE206621) and multiplex immunofluorescence in a rat periodontitis model. Results: PI showed broader transcriptomic perturbation than PD (1,832 PI-specific and 820 PD-specific cross-validated DEGs). A total of 693 robust common DEGs with 99.0% directional concordance defined a shared inflammatory core enriched in cytokine signaling, B-cell activation, and osteoclast differentiation. Single-cell analysis resolved 15 cell populations and marked immune remodeling in periodontitis. Dual deconvolution identified plasma cell enrichment as the most reproducible infiltration feature across datasets and methods. CellChat revealed disease-associated remodeling of the plasma cell communication network, with endothelial cells as dominant senders and APP-CD74 as the strongest candidate incoming axis. Spatial transcriptomics showed a 14.43-fold increase in spot-level APP-CD74 co-enrichment in periodontitis-affected tissue, and multiplex immunofluorescence supported enhanced protein-level coupling between APP Conclusions: Plasma cell enrichment is the most robust shared immune feature of PD and PI. In periodontitis, convergent multi-omics and tissue-level evidence supports a candidate endothelial-plasma cell communication program centered on APP-CD74, suggesting that endothelial-plasma cell niche remodeling may sustain periodontal inflammation and inform host-modulatory strategies. Importantly, this axis was established only in periodontitis; its relevance to peri-implantitis remains inferential and will require direct single-cell and spatial validation in peri-implant tissue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.